Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction

Prostaglandins and Other Lipid Mediators

Volumn 106, Issue , 2013, Pages 53-61

  Knapp, Małgorzata ^a   Lisowska, Anna ^a   Zabielski, Piotr ^a   Musiał, Włodzimierz ^a   Baranowski, Marcin ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramide; Human; Red blood cells; Sphinganine; Sphingosine kinase; Thrombocytes

Indexed keywords

CERAMIDE; SPHINGANINE; SPHINGANINE 1 PHOSPHATE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LIPID METABOLISM; MALE; SPHINGOSINE 1 PHOSPHATE BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR ENDOTHELIUM;

CERAMIDE; HUMAN; RED BLOOD CELLS; SPHINGANINE; SPHINGOSINE KINASE; THROMBOCYTES;

ACUTE DISEASE; AGED; ERYTHROCYTES; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SPHINGOSINE;

EID: 84887040330     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.10.001     Document Type: Article

References (45)

1. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
2. T.A. Taha, Y.A. Hannun, and L.M. Obeid Sphingosine kinase: biochemical and cellular regulation and role in disease J Biochem Mol Biol 39 2006 113 131
3. C.K. Means, and J.H. Brown Sphingosine-1-phosphate receptor signalling in the heart Cardiovasc Res 82 2009 193 200
4. S. Spiegel, and S. Milstien Functions of a new family of sphingosine-1-phosphate receptors Biochim Biophys Acta 1484 2000 107 116
5. Y. Yatomi Plasma sphingosine 1-phosphate metabolism and analysis Biochim Biophys Acta 1780 2008 606 611
6. M. Baranowski, and J. Gorski Heart sphingolipids in health and disease Adv Exp Med Biol 721 2011 41 56
7. J.S. Karliner Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress Biochim Biophys Acta 1831 2013 203 212
8. M. Knapp Cardioprotective role of sphingosine-1-phosphate J Physiol Pharmacol 62 2011 601 607
9. J.S. Karliner, N. Honbo, and K. Summers The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes J Mol Cell Cardiol 33 2001 1713 1717
10. S. Lecour, R.M. Smith, and B. Woodward Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection J Mol Cell Cardiol 34 2002 509 518
11. Z.Q. Jin, H.Z. Zhou, and P. Zhu Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts Am J Physiol Heart Circ Physiol 282 2002 H1970 H1977
12. U. Hofmann, N. Burkard, and C. Vogt Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion Cardiovasc Res 83 2009 285 293
13. Z.Q. Jin, J. Zhang, and Y. Huang A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury Cardiovasc Res 76 2007 41 50
14. H.F. Duan, H. Wang, and J. Yi Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure Hum Gene Ther 18 2007 1119 1128
15. N. Murata, K. Sato, and J. Kon Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions Biochem J 352 Pt 3 2000 809 815
16. Z.Q. Jin, E.J. Goetzl, and J.S. Karliner Sphingosine kinase activation mediates ischemic preconditioning in murine heart Circulation 110 2004 1980 1989
17. D.A. Vessey, M. Kelley, and L. Li Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury Med Sci Monit 12 2006 BR318 BR324
18. D.A. Vessey, L. Li, and N. Honbo Karliner JS. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning Am J Physiol Heart Circ Physiol 297 2009 H1429 H1435
19. Z.Q. Jin, J.S. Karliner, and D.A. Vessey Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation Cardiovasc Res 79 2008 134 140
20. S.J. Somers, M. Frias, and L. Lacerda Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection Cardiovasc Drugs Ther 26 2012 227 237
21. L. Gomez, M. Paillard, and M. Price A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection Basic Res Cardiol 106 2011 1341 1353
22. S. Morel, M.A. Frias, and C. Rosker The natural cardioprotective particle HDL modulates connexin43 gap junction channels Cardiovasc Res 93 2012 41 49
23. M. Knapp, M. Baranowski, and A. Lisowska Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure Adv Med Sci 57 2012 100 105
24. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
25. P. Hanel, P. Andreani, and M.H. Graler Erythrocytes store and release sphingosine 1-phosphate in blood FASEB J 21 2007 1202 1209
26. J.K. Min, H.S. Yoo, and E.Y. Lee Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase Anal Biochem 303 2002 167 175
27. R. Bose, P. Chen, and A. Loconti Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35 J Biol Chem 273 1998 28852 28859
28. D.A. Vessey, M. Kelley, and J.S. Karliner A rapid radioassay for sphingosine kinase Anal Biochem 337 2005 136 142
29. A.E. Alewijnse, and S.L. Peters Sphingolipid signalling in the cardiovascular system: good, bad or both Eur J Pharmacol 585 2008 292 302
30. M. Knapp, M. Zendzian-Piotrowska, and A. Blachnio-Zabielska Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat Basic Res Cardiol 107 2012 294
31. K.J. Sattler, S. Elbasan, and P. Keul Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease Basic Res Cardiol 105 2010 821 832
32. E.E. Egom, T.M. Mohamed, and M.A. Mamas Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury Am J Physiol Heart Circ Physiol 301 2011 H1487 H1495
33. R. Tao, J. Zhang, and D.A. Vessey Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes Cardiovasc Res 74 2007 56 63
34. J. Zhang, N. Honbo, and E.J. Goetzl Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia Am J Physiol Heart Circ Physiol 293 2007 H3150 H3158
35. G. Theilmeier, C. Schmidt, and J. Herrmann High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor Circulation 114 2006 1403 1409
36. G.P. Deshpande, J. McCarthy, and H. Mardikar Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF) Cardiovasc Drugs Ther 24 2010 459 460
37. R. Pappu, S.R. Schwab, and I. Cornelissen Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 2007 295 298
38. K. Venkataraman, Y.M. Lee, and J. Michaud Vascular endothelium as a contributor of plasma sphingosine 1-phosphate Circ Res 102 2008 669 676
39. K.M. Argraves, A.A. Sethi, and P.J. Gazzolo S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease Lipids Health Dis 10 2011 70
40. D.H. Deutschman, J.S. Carstens, and R.L. Klepper Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate Am Heart J 146 2003 62 68
41. J.R. Van Brocklyn, and J.B. Williams The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death Comp Biochem Physiol B: Biochem Mol Biol 163 2012 26 36
42. A. Huwilera, T. Kolterb, and J. Pfeilschiftera Physiology and pathophysiology of sphingolipid metabolism and signaling Biochim Biophys Acta 1485 2000 63 99
43. H. Schmidt, R. Schmidt, and G. Geisslinger LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples Prostaglandins Other Lipid Mediat 81 2006 162 170
44. T. Ulrych, A. Bohm, and A. Polzin Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation J Thromb Haemost 9 2011 790 798
45. Y. Yatomi, Y. Igarashi, and L. Yang Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum J Biochem (Tokyo) 121 1997 969 973